Effects of Losartan on expression of connexins at the early stage of atherosclerosis in rabbits
- PMID: 20479953
- PMCID: PMC2869452
- DOI: 10.7150/ijms.7.82
Effects of Losartan on expression of connexins at the early stage of atherosclerosis in rabbits
Abstract
Aim: to investigate effects of Losartan on expression of connexin 40 and 43 (Cx40 and Cx43), in arteries at the early stage of atherosclerosis in a rabbit model.
Methods: A total of 28 male New Zealand white rabbits were divided into following groups: control group, high fat diet group, and Losartan group (10 mg/kg/day). Losartan was administrated in food for two weeks. Iliac arteries were obtained for immunohistochemistry, transmission electron microscopy, Western blot, and reverse transcriptase-polymerase chain reaction (RT-PCR).
Results: Transmission electron microscopy revealed abundant gap junctions between neointimal smooth muscle cells (SMCs), which were markedly reduced by treatment. RT-PCR and Western blot assay showed that the mRNA and protein expression of Cx40 and Cx43 were elevated in the neointimal area at the early stage of atherosclerosis. The mRNA and protein expression of Cx43 were significantly down-regulated by losartan treatment but those of Cx40 were not markedly changed.
Conclusion: Cx40 and Cx43 in the neointimal SMCs were up-regulated at the early stage of atherosclerosis. Losartan (an angiotensin-converting enzyme inhibitor) could reduce neointima proliferation and down-regulate the elevated protein expression of Cx43, suggesting the rennin-angiotensin system (RAS) plays an important role in the remodeling of gap junction between ventricular myocytes under pathological conditions.
Keywords: balloon angioplasty; connexin; gap junction; statin; vascular proliferation.
Conflict of interest statement
Conflict of Interest: The authors have declared that no conflict of interest exists.
Figures





Similar articles
-
Effect of ramipril on the regulation of the expression of connexins 40 and 43 in a rabbit model of arterial balloon injury.Mol Med Rep. 2012 Sep;6(3):565-9. doi: 10.3892/mmr.2012.944. Epub 2012 Jun 12. Mol Med Rep. 2012. PMID: 22711019
-
Regulation of connexin expression after balloon injury: possible mechanisms for antiproliferative effect of statins.Am J Hypertens. 2005 Sep;18(9 Pt 1):1146-53. doi: 10.1016/j.amjhyper.2005.03.746. Am J Hypertens. 2005. PMID: 16245407
-
Statins reduce connexin40 and connexin43 expression in atherosclerotic aorta of rabbits.Int J Cardiol. 2005 Apr 28;100(3):467-75. doi: 10.1016/j.ijcard.2004.12.005. Int J Cardiol. 2005. PMID: 15837092
-
Multiple approaches for the evaluation of connexin-43 expression and function in macrophages.J Immunol Methods. 2024 Oct;533:113741. doi: 10.1016/j.jim.2024.113741. Epub 2024 Aug 5. J Immunol Methods. 2024. PMID: 39111361 Review.
-
Expression pattern of different gap junction connexins is related to embryo implantation.Int J Dev Biol. 1996 Feb;40(1):361-7. Int J Dev Biol. 1996. PMID: 8735949 Review.
Cited by
-
Combination of fluvastatin and losartan relieves atherosclerosis and macrophage infiltration in atherosclerotic plaques in rabbits.Acta Pharmacol Sin. 2011 Oct;32(10):1259-65. doi: 10.1038/aps.2011.95. Epub 2011 Sep 12. Acta Pharmacol Sin. 2011. PMID: 21909126 Free PMC article.
-
Establishment of an interleukin-1β-induced inflammation-activated endothelial cell-smooth muscle cell-mononuclear cell co-culture model and evaluation of the anti-inflammatory effects of tanshinone IIA on atherosclerosis.Mol Med Rep. 2015 Aug;12(2):1665-76. doi: 10.3892/mmr.2015.3668. Epub 2015 Apr 23. Mol Med Rep. 2015. PMID: 25936371 Free PMC article.
-
Connexin43 siRNA promotes HUVEC proliferation and inhibits apoptosis induced by ox-LDL: an involvement of ERK signaling pathway.Mol Cell Biochem. 2014 Sep;394(1-2):101-7. doi: 10.1007/s11010-014-2085-4. Epub 2014 May 16. Mol Cell Biochem. 2014. PMID: 24833468
References
-
- Chadjichristos CE, Derouette JP, Kwak BR. Connexins in atherosclerosis. Adv Cardiol. 2006;42:255–67. - PubMed
-
- Kwak BR, Mulhaupt F, Veillard N, Gros DB, Mach F. Altered pattern of vascular connexin expression in atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2002;22(2):225–30. - PubMed
-
- Balakumar P, Kaur T, Singh M. Potential target sites to modulate vascular endothelial dysfunction: current perspectives and future directions. Toxicology. 2008;245(1-2):49–64. - PubMed
-
- Li J, Hirose N, Kawamura M, Arai Y. Antiatherogenic effect of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist in the cholesterol-fed rabbits. Atherosclerosis. 1999;143:315–26. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous